Business Context and Reporting Period
This Form 6-K filing by uniQure N.V. was submitted on March 3, 2015. The report serves to furnish the Company's Management's Discussion and Analysis (MD&A) and unaudited financial statements for the nine-month periods ended September 30, 2014, and September 30, 2013. The financial data is incorporated by reference from a previous filing dated December 1, 2014.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced exhibits (Exhibit 99.1 and Exhibit 99.2) which are not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance or operations between the nine-month periods ended September 30, 2014, and 2013. Such analysis is located in the referenced MD&A document.
Guidance, Outlook, and Risks
The provided text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. This information is expected to be found in the incorporated Management's Discussion and Analysis exhibit.
Investor Verification Checklist
- Verify the specific revenue and net loss figures in the unaudited financial statements (Exhibit 99.2) for the nine months ended September 30, 2014.
- Review the cash burn rate and remaining liquidity in the referenced MD&A to assess runway.
- Confirm the status of clinical trials and regulatory milestones discussed in the MD&A (Exhibit 99.1).
- Check for any updates on debt covenants or financing activities since the December 1, 2014 filing.